Hims & Hers’ $49 weight-loss pill jolts everyone, except its stock

Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its announcement of a weight-loss pill with a $49-a-month introductory price. Its shares ended down anyway. That pattern is nothing new for investors in the compounding company, an upstart competitor to established drugmakers that became a momentum-stock darling before entering into a […]